Drug
En3267
En3267: highest development phase Phase 3, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| EN3267 NCT00263575 | Phase 3 | Pain |
Latest
No recent events.
Follow En3267 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.